At the systemic level, GLP-1 RAs improve insulin sensitivity in peripheral tissues (muscle, adipose), reduce circulating free fatty acid flux to the liver, suppress hypothalamic appetite circuits to promote weight loss, and lower systemic pro-inflammatory cytokines (TNF-, IL-1, IL-6), thereby reducing the hepatic inflammatory milieu indirectly [7,26,30]
Use daily for visible regrowth, then shift to maintenance for ongoing support
Reduced levels of glutathione have been associated with increased disease risk and progression, including NAFLD and other liver pathologies
GLP-1 (glucagon-like peptide-1) is a hormone produced by the small intestine that helps regulate appetite and blood sugar levels
The good news is that adaptation at higher doses typically happens faster than the initial adjustment
After two months, even perfectly stored compounded semaglutide may have lost enough potency to reduce effectiveness